Skip to content

Clinical trials

Completed Phase 1 Pathologic Processes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pathologic Processes Phase: Phase 1 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20131
20171
20181
20202
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AVEO Pharmaceuticals, Inc.1
Contineum Therapeutics1
Corcept Therapeutics1
Indiana University1
Medicines for Malaria Venture1
Meryx, Inc.1
NYU Langone Health1
Technical University of Munich1
Tracon Pharmaceuticals Inc.1
University of Maryland, Baltimore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pathologic Processes11
Inflammation3
Neoplasms3
Neoplastic Processes3
Cardiovascular Diseases2
Mental Disorders2
Neoplasm Metastasis2
Substance-Related Disorders2
ACTH Syndrome, Ectopic1
Adrenal Cortex Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.